Home
HEALTH CARE
Allergy and hay fever
Antineoplastic and immunomodulating agents
Circulatory system
Colds and flu
Dermatology
Digestive system
Eyes
For diabetics
Homeopathy
Musculoskeletal system
Non-sex hormones
Nutrikosmetics
Pain
Preparations for the treatment of infections
Sex and contraception
The immune system
The nervous system
Urogenital tract
Vitamins and minerals
HEALTHY LIFESTYLE
For athletes
Healthy food
Slimming
HYGIENE
Disinfection
Ear hygiene
Hot and cold compresses
Intimate hygiene
Laundry products
Oral hygiene
Slices and sticks
Urinary incontinence
COSMETICS
Cosmetic articles
For eyelashes and eyebrows
For face
For hair
For hands and nails
For the body
Soap
Sunbathing
To the feet
To the mouth
FOR HIM
Cosmetics for men
Health
PREGNANCY AND MOTHERHOOD
Accessories
Cosmetics for pregnant women
Health in pregnancy
Supporting fertility
CHILD
Baby nutrition
Child health
Cosmetics for children
Hygiene items for children
Oral hygiene (for children)
Scrolling
HEALTH CARE
Atorvastatin-Teva 20mg 30 tablets — Made in Spain — Free Delivery
Atorvastatin-Teva 20mg 30 tablets — Made in Spain — Free Delivery
Brand:
TEVA
Product Code:
Atorvastatin-Teva
Availability:
In Stock
$23.03
Add to Cart
Description
Product d
escription
Atorvastatin-Teva tablets are indicated for:
preventing cardiovascular disease;
reducing the risk of myocardial infarction;
reducing the risk of stroke;
reducing the risk of revascularization procedures and angina pectoris.
reducing the risk of non-fatal myocardial infarction;
reducing the risk of fatal and non-fatal stroke;
reducing the risk of hospitalization due to congestive heart failure.
Structure
Active substance: atorvastatin;
1 coated tablet contains 10 mg or 20 mg, 40 mg, or 80 mg of atorvastatin (in the form of atorvastatin calcium);
Excipients:
core: microcrystalline cellulose, sodium carbonate, maltose, sodium croscarmellose, magnesium stearate;
shell: hypromellose (E 464), hydroxypropyl cellulose, triethyl citrate (E 1505), polysorbate 80, titanium dioxide (E 171).
Contraindications
Hypersensitivity to any of the components of this medication.
Active liver disease, which may include a sustained increase in hepatic transaminase activity of unknown etiology.
During pregnancy and breastfeeding.
Women of childbearing age who do not use contraceptives.
Mode of application
Atorvastatin is intended for oral administration. The dose is taken in full 1 time per day every day, at any time of the day, regardless of food intake.
Before using atorvastatin, the patient should start a standard cholesterol-lowering diet and follow it in the future during treatment with atorvastatin.
The dose is selected individually in accordance with the baseline level of LDL cholesterol, the goal of therapy and the patient's response. The maximum dose is 80 mg once a day.
Application features
Pregnant
Contraindicated.
Children
From 10 years old.
Drivers
Has a very insignificant effect on the reaction rate when driving or working with other mechanisms.
Overdose
There is no specific treatment for atorvastatin overdose. In case of an overdose, the patient should be treated symptomatically and supportive measures should be taken if necessary. Due to the high degree of binding of the drug to plasma proteins, one should not expect a significant increase in the clearance of atorvastatin using hemodialysis.
Side effects
Adverse reactions reported in clinical and post-marketing studies include:
General disorders: malaise, pyrexia, asthenia, chest pain, peripheral edema, fatigue.
Interaction
The risk of developing myopathy during treatment with statins increases with the simultaneous use of fibric acid derivatives, lipid-modifying doses of niacin, cyclosporine, or potent inhibitors of CYP 3A4 (for example, clarithromycin, HIV protease inhibitors and itraconazole).
Grapefruit juice. Contains one or more components that inhibit CYP 3A4 and can increase plasma concentrations of atorvastatin, especially with excessive consumption of grapefruit juice (more than 1.2 liters per day).
Atorvastatin and its metabolites are substrates for the OATP1B1 transporter. OATP1B1 inhibitors (eg cyclosporin) can increase the bioavailability of atorvastatin. The AUC value of atorvastatin significantly increased with the simultaneous use of atorvastatin at a dose of 10 mg and cyclosporin at a dose of 5.2 mg / kg / day compared with the use of atorvastatin alone. The simultaneous use of atorvastatin and cyclosporine should be avoided.
Storage conditions
Keep out of the reach of children at a temperature not exceeding 30 ° C.
Shelf life is 2 years.
0 reviews
There are no reviews for this product.